PW Medtech Group Co. Ltd. has announced a voluntary share repurchase under the Repurchase Mandate. The company has the authorization to repurchase up to 10% of its total shares in issue, excluding treasury shares, up to 148,673,509 shares, as approved during the annual general meeting on June 10, 2025. The repurchase will be subject to market conditions and determined at the Board's discretion, with no assurance on timing, quantity, or price. The repurchase will be financed from the company's existing available cash.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PW Medtech Group Co. Ltd. published the original content used to generate this news brief on July 04, 2025, and is solely responsible for the information contained therein.